CLINICAL_TRIALS
trial_result
· 2016-04-12
Clinical Trial Update: Global Performance Evaluation of the AMS CONTINUUM™ Device [Phase 4]
Summary
Phase 4 global performance evaluation of the AMS CONTINUUM device for prostate cancer has been completed. The results were posted in 2016.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: American Medical Systems | Conditions: Prostate Cancer | Phase 4 | Status: COMPLETED | Results posted: 2016-04-12